Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Activity Code(s) Title
NOT-HD-24-015 January 1, 2027 Notice of NICHD Participation in PAR-23-222 "Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 Clinical Trial Not Allowed)"
NOT-HD-24-001 January 1, 2027 Notice of Extension of the Expiration Date for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"
PA-24-141 January 8, 2027 R13 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
NOT-HD-24-008 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
RFA-OD-24-012 September 7, 2024 T32 Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
NOT-HD-24-011 January 1, 2027 Request for Information (RFI): Inviting Comments and Suggestions on the Eunice Kennedy Shriver National Institute of Child Health and Human Developments Support of Extramural Research Training and Early Career Development
NOT-HD-24-004 January 1, 2027 Notice of NICHD Participation in PAR-24-077: "Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)"
NOT-HD-24-013 January 1, 2027 Phase-out and Termination of NICHD Participation in the NIH MERIT (R37) Program
RFA-OD-24-013 May 29, 2026 K12 Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
NOT-HD-24-005 January 1, 2027 Notice of NICHD Withdrawal from Participation in PAR-24-043 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
NOT-HD-24-006 January 1, 2027 Notice of NICHD Withdrawal from Participation in PAR-24-063 " Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
RFA-OD-24-007 July 2, 2026 F99/K00 INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
RFA-AG-25-002 July 3, 2024 U54 Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
NOT-OD-24-058 January 8, 2027 U24,R01,R21,R34,UG3/UH3,R03 Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
RFA-MH-25-105 July 2, 2026 U24 BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
RFA-MH-25-100 January 18, 2025 U01 BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)
RFA-MH-25-170 October 10, 2026 R01 BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
RFA-MH-25-171 October 10, 2026 R21 BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
NOT-HD-24-007 January 1, 2027 Notice of NICHD Participation in PAR-23-144 "Strengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions")
NOT-AR-25-004 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
top of pageBACK TO TOP